Trohman RG, Sahu J
Rush-Presbyterian-St. Luke's Medical Center, 1750 West Harrison, Suite 1091 Jelke, Chicago, IL 60612, USA.
Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):259-268. doi: 10.1007/s11936-999-0042-4.
Despite recurrences of ventricular tachycardia, patients with arrhythmogenic right ventricular dysplasia have a favorable prognosis with medical therapy. Because of the low incidence of arrhythmic death and the problems involved in identifying patients at high risk, it is difficult to evaluate the benefits of interventional therapies (ablation, surgery, and implantable cardioverter-defibrillators).
尽管室性心动过速会复发,但致心律失常性右心室发育不良患者接受药物治疗后预后良好。由于心律失常性死亡的发生率较低,且难以识别高危患者,因此很难评估介入治疗(消融、手术和植入式心脏复律除颤器)的益处。